Namrata Vijayvergia

11PUBLICATIONS
57CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 16, 2026
Cobimetinib + Vemurafenib in Patients With BRAF V600E-Mutant Papillary Thyroid and Biliary Tract Cancers: Results From the TAPUR Study.

|Sep 24, 2026
Comparison of geriatric assessment with provider's clinical assessment among older adults with gastroesophageal cancer.

|Sep 27, 2025
Sequencing Choices and Real-World Clinical Management in Advanced Grade 2/3 GEP-NET Treatment: The Emerging Role of PRRT.

Aman Chauhan, Thorvardur R Halfdanarson, Namrata Vijayvergia

|May 09, 2025
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.

Kimberly Perez, Jaydira Del Rivero, Erin B Kennedy

|Sep 07, 2024
TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.

Patrick M Boland, Sarbajit Mukherjee, Iman Imanirad

|May 15, 2024
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Timothy L Cannon, Michael Rothe, Pam K Mangat

Pageof 2

Frequent Collaborators

3 joint publications

Thorvardur R Halfdanarson

2 joint publications

Heloisa P Soares

2 joint publications

James R Howe

2 joint publications

Jaydira Del Rivero